This portal should only be accessed by patients who have been prescribed this medicine by their Healthcare Professional.

 

This portal should only be accessed by patients who have been prescribed this medicine by their Healthcare Professional.

These resources are only to be provided to patients who have already been prescribed Hemlibra® (emicizumab) by their physician.

They need to be used along with the Patient Information Leaflets and additional Risk Minimisation Materials provided to you by your healthcare provider, namely ‘Hemlibra® (emicizumab): Patient/Carer Guide‘  and ‘Hemlibra® (emicizumab): Patient Alert Card’.

 

Contact Us

These contact details do not replace the advice of a physician. Roche cannot respond to questions about general medical information or questions regarding your personal medical condition.

Medications and diagnostics products cannot be directly ordered through this website.

Please note that we do not respond to form letters or e-mail campaigns.

Reporting of side effects.

Reporting side effects after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.

In the event of a suspected adverse event (side effect), please report it to:

The Drug Surveillance Centre
Pharmacovigilance Department 
Roche Products (Ireland) Limited
3004 Lake Drive, Citywest,
Naas Road, Dublin 24
Telephone: (01) 4690700
Email: ireland.drug_surveillance_centre@roche.com
Webform: https://medinfo.roche.com/ie/en.html

Or alternatively:

HPRA Pharmacovigilance
Website: www.hpra.ie


Our contact points: 

Pharmaceuticals

Roche Products (Ireland) Limited 
3004 Lake Drive
Citywest
Dublin 24
Ireland

Media

Maura McBride
Communications Partner

Roche Products (Ireland) Limited
Telephone: +353 (0)1 469 0700
Mobile: +353 (0)87 1012026

Your scientific questions about Roche products

Have a product information question? The Roche Medical Information department serves to communicate balanced information about our products.

Contact the Medical Information department:

Telephone: 01-4690700 
Email: ireland.druginfo@roche.com

Please note that Roche can not advise on medical treatments of individuals.

The attending physician is responsible for all decisions related to the prescribing of medication and medical treatment of the patient.

Diagnostics

Telephone: 1800 509 586 (freefone from Republic of Ireland)

Further contact details here

Patients and Healthcare professionals are asked to report any suspected adverse reactions.